Skip to main content
Clinical Trials/NCT06110364
NCT06110364
Withdrawn
Phase 3

Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions

Hunter Holmes Mcguire Veteran Affairs Medical Center1 site in 1 country20 target enrollmentJuly 19, 2023

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Premature Ventricular Contraction
Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Enrollment
20
Locations
1
Primary Endpoint
Assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions.
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

Prospective randomized control pilot study

Detailed Description

The primary aims of this investigator initiated study is : Aim 1: to assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions and Aim 2: to compare the efficacy of Lower-level Tragus stimulation and Heart rate variability- Biofeedback in suppression of Premature Ventricular Contractions.

Registry
clinicaltrials.gov
Start Date
July 19, 2023
End Date
August 13, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Hunter Holmes Mcguire Veteran Affairs Medical Center
Responsible Party
Principal Investigator
Principal Investigator

Jose Huizar

Associate Chief of Staff for Research and Development at VAMC, Professor of Medicine at VCU, Director, Arrhythmia and Device Clinic at VAMC and Affiliate Professor of Physiology and Biophysics VCU

Hunter Holmes Mcguire Veteran Affairs Medical Center

Eligibility Criteria

Inclusion Criteria

  • Normal Left Ventricular systolic function
  • Frequent PVCs

Exclusion Criteria

  • Current use of any (I and/or III) antiarrhythmic medication
  • Contraindication to use beta blockers and non-dihydropyridine calcium channel blockers
  • Complete Atrioventricular block and pacemaker dependent
  • Ongoing uncontrolled hypertension with systolic Blood Pressure\> 180
  • Family history of dilated Cardiomyopathy in a first degree relative
  • Alcohol use disorder or illicit drug use
  • Actively being treated Atrial fibrillation/ Flutter with Rapid Ventricular Response
  • Moderate to severe valve disorders
  • Patient with shortwave/microwave therapy equipment

Outcomes

Primary Outcomes

Assess the ability of non-invasive vagal nerve stimulation to suppress Premature Ventricular Contractions.

Time Frame: perspective 12-week study (each arm lasting two weeks with a one week washout between each arm)

Compare the effects of Premature Ventricular Contractions suppression between standard medical therapy and non-invasive vagal nerve stimulation.

Secondary Outcomes

  • Compare the efficacy of non-invasive vagal nerve stimulation via lower-level vagal stimulation and heart rate variability in suppression of Premature Ventricular Contractions.(perspective 12-week study (each arm lasting two weeks with a one-week washout between each arm))

Study Sites (1)

Loading locations...

Similar Trials